FY 2019 REVENUES
REVENUES GROWTH IN FY 2019
ONCOLOGY ORDERS GROWTH IN FY 2019
NON-GAAP EPS 1 GROWTH IN FY 2019
Long-term results of the Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic Cancers (SABR-COMET) study published June 2, 2020 in the Journal of Clinical Oncology...
Varian (NYSE: VAR) today announced two executive appointments. Michael Hutchinson has joined the company as Senior Vice President, Chief Legal Officer following the previously communicated...
Varian (NYSE: VAR) today announced that Dow Wilson, Chief Executive Officer, J. Michael Bruff, Chief Financial Officer, and Anshul Maheshwari, Vice President, Investor Relations and Treasurer will...
Varian (NYSE: VAR) today announced that J. Michael Bruff, Chief Financial Officer, Chris Toth, President, Varian Oncology Systems, and Anshul Maheshwari, Vice President, Investor Relations and...
View all press releases
View all events
Teleconference: Access from within the U.S. by dialing 1-877-869-3847, and from outside the U.S. by dialing 1-201-689-8261. Replay: Access from within the U.S. by dialing 1-877-660-6853 and from...
View more events
Q2 FY20 Earnings Results
View all quarterly results
FY19 Annual Report
FY19 Sustainability Report
View all reports
VP, Treasurer and Investor Relations
1 650 424 6081
Varian Corporate Headquarters
3100 Hansen Way
Palo Alto, CA 94304-1038
Stay up to date on the latest investor information.